Pharmaceutical Liability
Updates on Risks Surrounding Proton Pump Inhibitors (PPIs)
Proton pump inhibitors (PPIs) decrease the production of stomach acid that is responsible for the development of ulcers in the stomach, duodenum and esophagus. However,…
Read MoreZostavax 2019 Litigation Updates
Zostavax, a vaccine administered to protect against herpes zoster, otherwise known as shingles, is now being contested in approximately 550 cases in multidistrict litigation (MDL).…
Read MoreUpdates on Safety Doubts Surrounding Nuplazid
In June of 2016, antipsychotic pharmaceutical drug Nuplazid was approved as a new method of treating psychosis in Parkinson’s patients. Since it’s release over two…
Read MoreDrug Watch — Lemtrada
The Food and Drug Administration (FDA) has recently added a warning to the prescribing information of Lemtrada, a pharmaceutical drug used to treat serious multiple…
Read MoreCarcinogenic Impurities in Valsartan Lead to Legal Action
On July 13th, 2018, the Food and Drug Administration (FDA) announced that several pharmaceutical companies were voluntarily recalling certain batches of valsartan-containing blood pressure medication…
Read MoreThe Opioid Crisis by The Numbers
Opioid Liability for Injury and Death
The opioid industry is facing unprecedented backlash from private citizens and government officials as more individuals fall victim to addiction, injury and even death related…
Read MoreJury Awards $27.8 Million in Damages to Patient Injured by Xarelto®
On December 5, 2017, a Philadelphia jury ordered Bayer AG and Johnson & Johnson to pay over $27 million in damages to a patient injured…
Read MoreFDA: Clinical Trials Show Increased Risk of Amputation with Invokana
Recent safety communications published by the US Food and Drug Administration indicate that type 2 diabetes drug, Invokana (canagliflozin), can cause increased risk for foot…
Read MoreWhat Patients Need to Know About Actos
The pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss the dangers of Actos—a common Type 2 Diabetes medication. Actos, a common Type…
Read More